Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
Bangladesh · Delayed Price · Currency is BDT 219.60
0.00 (0.00%)
At close: Oct 19, 2026
DSE:SQURPHARMA Market Cap
DSE:SQURPHARMA has a market cap or net worth of 194.66 billion as of October 22, 2026. It is the 7,617th most valuable company in the world and the 2nd biggest in Bangladesh. Its market cap has increased by 5.07% in one year.
Market Cap
194.66B
Enterprise Value
122.46B
Revenue
83.53B
Global Rank
Country Rank
#2 Bangladesh
PE Ratio
7.53
ChartMarket Cap Chart
Since April 18, 2002, DSE:SQURPHARMA's market cap has increased from 3.10B to 194.66B, an increase of 6,174.45%. That is a compound annual growth rate of 18.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 194.66B | 10.57% |
| Dec 30, 2025 | 176.05B | -8.77% |
| Dec 30, 2024 | 192.98B | 3.52% |
| Dec 28, 2023 | 186.42B | 0.24% |
| Dec 29, 2022 | 185.98B | -2.10% |
| Dec 30, 2021 | 189.97B | -2.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 65.00B |
| Renata | 51.25B |
| Unilever Consumer Care | 38.40B |
| Beacon Pharmaceuticals | 22.20B |
| The ACME Laboratories | 16.38B |
| Asiatic Laboratories | 13.49B |
| The IBN SINA Pharmaceutical Industry | 9.44B |
| Orion Pharma | 6.76B |